Adulteration of hypoglycemic products: the silent threat [PDF]
Romanian Journal of Medical Practice, 2023 Background. The growing tendency toward the adulteration of hypoglycemic products in the market to increase the seller’s profits, the increased promotions of such products by unscrupulous promoters, and the higher rate of consumption by diabetic patients
Raniah I. Alnaser +2 more
doaj +1 more source
Blood glucose, antidiabetic drugs, and risk of stroke [PDF]
Precision and Future Medicine, 2021 Diabetes mellitus is a well-established risk factor for stroke. Among people without baseline diabetes or cardiovascular disease, a low fasting glucose level of < 70 mg/dL is associated with an increased risk of stroke.
Meng Lee, Bruce Ovbiagele
doaj +1 more source
Hypoglycemic agents and incidence of pancreatic cancer in diabetic patients: a meta-analysis
Frontiers in Pharmacology, 2023 Background and aims: Hypoglycemic agents are the primary therapeutic approach for the treatment of diabetes and have been postulated to impact pancreatic cancer (PC) incidence in diabetic patients.
Zimo Zhao, Xinyi He, Yan Sun
doaj +1 more source
THE EFFECTS OF DIET AND HYPOGLYCEMIC AGENTS ON FASTING BLOOD SUGAR AND GLYCOSYLATED HAEMOGLOBIN CONCENTRATIONS IN TYPE TWO DIABETIC PATIENTS IN MOSUL POPULATION [PDF]
The Medical Journal of Basrah University, 2007 The study was conducted on 210 patients of both sexes suffering from Type 2 Diabetes Mellitus to investigate the effected of diet or hypoglycemic agents therapy on fasting blood sugar (FBS) and glycosylated haemoglobin (HbA1c).
Wail Moneer Mohammed Sadiq +1 more
doaj +1 more source
Journal of Pharmaceutical Health Care and Sciences, 2020 Background Patients with diabetes are at higher risk of developing polypharmacy because of the high frequency of comorbidities. There have been several reports on the hypoglycemic risk of the combination of hypoglycemic agents and other medications. This
Tomoyuki Saito +3 more
doaj +1 more source
Repositioning of Verrucosidin, a purported inhibitor of chaperone protein GRP78, as an inhibitor of mitochondrial electron transport chain complex I. [PDF]
, 2013 Verrucosidin (VCD) belongs to a group of fungal metabolites that were identified in screening programs to detect molecules that preferentially kill cancer cells under glucose-deprived conditions.
Chen, Thomas C +8 more
core +6 more sources
Pharmacogenetics of hypoglycemic agents
Сахарный диабет, 2015 Despite the increase in the number of hypoglycemic agents, 35%–40% of patients with diabetes are unable to achieve adequate glycemic control. One of the reasons is the genetic heterogeneity of diabetes mellitus, requiring different treatment approaches ...
Irina Vladimirovna Kononenko +3 more
doaj +1 more source
Comparison of glycemic excursion in patients with new onset type 2 diabetes mellitus before and after treatment with repaglinide [PDF]
, 2013 Due to industrialization and sedentary life, incidence of type 2 diabetes (DM2) is increasing seriously. Repaglinide is a glucose reducing agent that predominantly reduces post-prandial glucose.
Bonakdaran, S. +4 more
core +1 more source
Design, synthesis and pharmacological evaluation of novel vanadium-containing complexes as antidiabetic agents. [PDF]
PLoS ONE, 2014 Based on the data about structure and antidiabetic activity of twenty seven vanadium and zinc coordination complexes collected from literature we developed QSAR models using the GUSAR program.
Elena V Fedorova +5 more
doaj +1 more source
Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia [PDF]
, 2011 OBJECTIVE: Lactic acidosis has been associated with use of metformin. Hypoglycemia is a major concern using sulfonylureas. The aim of this study was to compare the risk of lactic acidosis and hypoglycemia among patients with type 2 diabetes using oral ...
Bodmer, Michael +4 more
core +2 more sources